These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16150852)

  • 1. Acupuncture treatment in irritable bowel syndrome.
    Schneider A; Enck P; Streitberger K; Weiland C; Bagheri S; Witte S; Friederich HC; Herzog W; Zipfel S
    Gut; 2006 May; 55(5):649-54. PubMed ID: 16150852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrinological effects of acupuncture treatment in patients with irritable bowel syndrome.
    Schneider A; Weiland C; Enck P; Joos S; Streitberger K; Maser-Gluth C; Zipfel S; Bagheri S; Herzog W; Friederich HC
    Complement Ther Med; 2007 Dec; 15(4):255-63. PubMed ID: 18054727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sham acupuncture is as efficacious as true acupuncture for the treatment of IBS: A randomized placebo controlled trial.
    Lowe C; Aiken A; Day AG; Depew W; Vanner SJ
    Neurogastroenterol Motil; 2017 Jul; 29(7):. PubMed ID: 28251729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life.
    Choi CH; Jo SY; Park HJ; Chang SK; Byeon JS; Myung SJ
    J Clin Gastroenterol; 2011 Sep; 45(8):679-83. PubMed ID: 21301358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of participation in a mindfulness programme with bowel symptoms, gastrointestinal symptom-specific anxiety and quality of life.
    Kearney DJ; McDermott K; Martinez M; Simpson TL
    Aliment Pharmacol Ther; 2011 Aug; 34(3):363-73. PubMed ID: 21651595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term success of GUT-directed group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial.
    Moser G; Trägner S; Gajowniczek EE; Mikulits A; Michalski M; Kazemi-Shirazi L; Kulnigg-Dabsch S; Führer M; Ponocny-Seliger E; Dejaco C; Miehsler W
    Am J Gastroenterol; 2013 Apr; 108(4):602-9. PubMed ID: 23419384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study.
    Brun-Strang C; Dapoigny M; Lafuma A; Wainsten JP; Fagnani F
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1097-103. PubMed ID: 17998835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptom management for irritable bowel syndrome: a pilot randomized controlled trial of acupuncture/moxibustion.
    Anastasi JK; McMahon DJ; Kim GH
    Gastroenterol Nurs; 2009; 32(4):243-55. PubMed ID: 19696601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative observation on therapeutic effects between acupuncture and western medication for diarrhea-predominant irritable bowel syndrome].
    Li H; Pei LX; Zhou JL
    Zhongguo Zhen Jiu; 2012 Aug; 32(8):679-82. PubMed ID: 23072079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.
    Leung WK; Wu JC; Liang SM; Chan LS; Chan FK; Xie H; Fung SS; Hui AJ; Wong VW; Che CT; Sung JJ
    Am J Gastroenterol; 2006 Jul; 101(7):1574-80. PubMed ID: 16863563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
    Bittner AC; Croffut RM; Stranahan MC
    Clin Ther; 2005 Jun; 27(6):755-61. PubMed ID: 16117982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of autogenic training on general improvement in patients with irritable bowel syndrome: a randomized controlled trial.
    Shinozaki M; Kanazawa M; Kano M; Endo Y; Nakaya N; Hongo M; Fukudo S
    Appl Psychophysiol Biofeedback; 2010 Sep; 35(3):189-98. PubMed ID: 19997775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind placebo-controlled study of mesalamine in post-infective irritable bowel syndrome--a pilot study.
    Tuteja AK; Fang JC; Al-Suqi M; Stoddard GJ; Hale DC
    Scand J Gastroenterol; 2012 Oct; 47(10):1159-64. PubMed ID: 22783919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation.
    Tack J; Müller-Lissner S; Bytzer P; Corinaldesi R; Chang L; Viegas A; Schnekenbuehl S; Dunger-Baldauf C; Rueegg P
    Gut; 2005 Dec; 54(12):1707-13. PubMed ID: 16020489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome.
    Saito YA; Rey E; Almazar-Elder AE; Harmsen WS; Zinsmeister AR; Locke GR; Talley NJ
    Am J Gastroenterol; 2010 Jan; 105(1):170-7. PubMed ID: 19809408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS.
    Jerndal P; Ringström G; Agerforz P; Karpefors M; Akkermans LM; Bayati A; Simrén M
    Neurogastroenterol Motil; 2010 Jun; 22(6):646-e179. PubMed ID: 20367800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopathy improves the severity of irritable bowel syndrome: a pilot randomized sham-controlled study.
    Florance BM; Frin G; Dainese R; Nébot-Vivinus MH; Marine Barjoan E; Marjoux S; Laurens JP; Payrouse JL; Hébuterne X; Piche T
    Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):944-9. PubMed ID: 22546751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study.
    Paré P; Gray J; Lam S; Balshaw R; Khorasheh S; Barbeau M; Kelly S; McBurney CR
    Clin Ther; 2006 Oct; 28(10):1726-35; discussion 1710-1. PubMed ID: 17157129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.